Eventide Asset Management, LLC Praxis Precision Medicines, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $1.53 Million - $9.94 Million	-876,938 Reduced 19.95%	3,518,062 $8.62 Million
Q1 2022 May 16, 2022	BUY	$10.21 - $20.29 $5.97 Million - $11.9 Million	584,401 Added 15.34%	4,395,000 $44.9 Million
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $309,629 - $531,197	23,546 Added 0.62%	3,810,599 $70.5 Million
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $5.01 Million - $9.05 Million	273,972 Added 7.8%	3,787,053 $67.7 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $95.7 Million - $196 Million	3,513,081 New	3,513,081 $184 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.